BPG is committed to discovery and dissemination of knowledge
Open-Access Journal
Editorial
Ethanol-induced hepatic autophagy: Friend or foe? 
Nabil Eid, Yuko Ito, Yoshinori Otsuki 
World J Hepatol 7(9):1154-1156. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1154
Review
Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome 
Adam S Bodzin, Ronald W Busuttil 
World J Hepatol 7(9):1157-1167. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1157
Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives 
Jan Erik Slotta, Otto Kollmar, Volker Ellenrieder, B Michael Ghadimi, Kia Homayounfar 
World J Hepatol 7(9):1168-1183. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1168
Intermediate hepatocellular carcinoma: How to choose the best treatment modality? 
Giovan Giuseppe Di Costanzo, Raffaella Tortora 
World J Hepatol 7(9):1184-1191. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1184
Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries 
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze 
World J Hepatol 7(9):1192-1208. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1192
Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside 
Bing Hu, Shuang-Shuang Wang, Qin Du 
World J Hepatol 7(9):1209-1232. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1209
Minireviews
Chronic hepatitis B infection in pregnancy 
Jennifer R Lamberth, Sheila C Reddy, Jen-Jung Pan, Kevin J Dasher 
World J Hepatol 7(9):1233-1237. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1233
Anticoagulation and antiplatelets as prophylaxis for hepatic artery thrombosis after liver transplantation 
Abdullah A Algarni, Moustafa M Mourad, Simon R Bramhall 
World J Hepatol 7(9):1238-1243. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1238
New prognostic markers in liver cirrhosis 
Vincent Di Martino, Delphine Weil, Jean-Paul Cervoni, Thierry Thevenot 
World J Hepatol 7(9):1244-1250. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1244
Valproic acid and nonalcoholic fatty liver disease: A possible association? 
Edoardo Farinelli, David Giampaoli, Anja Cenciarini, Ephraim Cercado, Alberto Verrotti 
World J Hepatol 7(9):1251-1257. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1251
Bone changes in alcoholic liver disease 
Emilio González-Reimers, Geraldine Quintero-Platt, Eva Rodríguez-Rodríguez, Antonio Martínez-Riera, Julio Alvisa-Negrín, Francisco Santolaria-Fernández 
World J Hepatol 7(9):1258-1264. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1258
Hepatitis B among Inuit: A review with focus on Greenland Inuit 
Karsten Fleischer Rex, Stig Andersen, Henrik Bygum Krarup 
World J Hepatol 7(9):1265-1271. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1265
Search for a cure for chronic hepatitis B infection: How close are we? 
Wah Wah Phyo, Alex Yu Sen Soh, Seng Gee Lim, Guan Huei Lee 
World J Hepatol 7(9):1272-1281. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1272
Key role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinoma 
Xin Zhang, Hui-Guo Ding 
World J Hepatol 7(9):1282-1286. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1282
Retrospective Study
Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant 
Kerstin Herzer, Angela Papadopoulos-Köhn, Anne Achterfeld, Ali Canbay, Katja Piras-Straub, Andreas Paul, Andreas Walker, Jörg Timm, Guido Gerken 
World J Hepatol 7(9):1287-1296. Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1287